BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Ralph Mueller  1     Christoph Schlag  2     Christoph Schmöcker  3     Roland Greinwald  1     Luc Biedermann  4     Michael Vieth  5     Alfredo J. Lucendo  6     Cecilio Santander  7     Alex Straumann     Petr Hruz     Ahmed Madisch     Stephan Miehlke     Stephen E. Attwood     Arjan Bredenoord     Stefan Schubert     Constanza Ciriza De Los Ríos     Alain M. Schoepfer     Jamal Hayat     Ulri    
1 Dr. Falk Pharma GmbH,Freiburg,Germany
2 Klinikum rechts der Isar - TU München,München,Germany
3 Sana Klinikum Lichtenberg,Berlin,Germany
4 University Hospital Zurich,Zurich,Switzerland
5 Klinikum Bayreuth,Bayreuth,Germany
6 Hospital General de Tomelloso,Tomelloso,Spain
7 Hospital Universitario de la

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing